Michael A. Dawes, MD

Clinical Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Michael Dawes, M.D. is Clinical Professor in Psychiatry at Boston University School of Medicine (BUSM). Dr. Dawes is Site Director at VA Boston Healthcare System, and was Program Director, BMC-VA Addiction Psychiatry Fellowship until 7.1.26. Dr. Dawes has been recipient of a Mentored Clinical Scientist Development Award from the National Institute on Drug Abuse, and has been PI and Site-PI on clinical and prospective studies and centers funded by the National Institutes of Health. He has experience designing and implementing quality improvement and systems redesign projects in the Veterans Healthcare Administration and has served as a site-PI for a multi-site study. Dr. Dawes has mentored and supervised faculty as well as many residents, fellows, and other trainees with interests in Addiction Psychiatry, Addiction Medicine, and clinical research in populations with substance use disorders. He has keen interest in training fellows using competency based medical education, and to do clinical research, including health services research and implementation science addressing access to treatment for individuals and populations with substance use disorders and various social determinants of health.

Publications

  • Published 2/10/2026

    Loeffel LB, Kwak HR, Shin J, Lee M, Jester DJ, Dawes M, Kudler HS, Jeste DV, Na PJ. Associations among social determinants of health and opioid use disorder and overdose: An umbrella review. Am J Addict. 2026 May; 35(3):339-361. PMID: 41667408.

    Read at: PubMed

  • Published 10/30/2024

    Sung ML, Black AC, Blevins D, Henry BF, Cates-Wessel K, Dawes MA, Hagle H, Joudrey PJ, Molfenter T, Levin FR, Fiellin DA, Edelman EJ. Clinician and Practice Characteristics Associated With Support of Office-based Methadone: Findings From a National Survey. J Addict Med. 2025 Mar-Apr 01; 19(2):150-156. PMID: 39475119.

    Read at: PubMed

  • Published 1/11/2022

    Sung ML, Black AC, Blevins D, Henry BF, Cates-Wessel K, Dawes MA, Drexler K, Hagle H, Molfenter T, Levin FR, Becker WC, Edelman EJ. Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers. J Addict Med. 2022 Sep-Oct 01; 16(5):505-513. PMID: 35020698.

    Read at: PubMed

  • Published 1/1/2022

    Hagedorn HJ, Wisdom JP, Gerould H, Pinsker E, Brown R, Dawes M, Dieperink E, Myrick DH, Oliva EM, Wagner TH, Harris AHS. Alcohol use disorder pharmacotherapy and treatment in primary care (ADaPT-PC) trial: Impact on identified barriers to implementation. Subst Abus. 2022; 43(1):1043-1050. PMID: 35467489.

    Read at: PubMed

  • Published 8/9/2021

    Blevins D, Henry BF, Sung M, Edelman EJ, Black AC, Dawes M, Molfenter T, Hagle H, Drexler K, Cates-Wessel K, Levin FR. Well-Being of Health Care Professionals Treating Opioid Use Disorder During the COVID-19 Pandemic: Results From a National Survey. Psychiatr Serv. 2022 Apr 01; 73(4):374-380. PMID: 34369804.

    Read at: PubMed

Other Positions

  • Site Director, Addiction Psychiatry Fellowship
    VA Boston Healthcare System
  • Co-Director, Interprofessional Advanced Fellowship in Addiction Treatment
    VA Boston Healthcare System